Cornerstone Capital Management Holdings’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
Cornerstone Capital Management Holdings's DGX Position: Q4 2017 in Review
Cornerstone Capital Management Holdings increased its Quest Diagnostics (DGX) stake by 8% in Q4 2017, buying an estimated $179K and bringing the position to 25,624 shares worth $2.52M. The position accounts for 0.02% of the portfolio, ranked #691.
Cornerstone Capital Management Holdings first reported a position in DGX in Q2 2013 and has held it in 19 quarters since. The position peaked at $9.22M in Q2 2015. 631 funds tracked by Wall St. Rank hold DGX as of Q4 2017.
- Cornerstone Capital Management Holdings held 25,624 shares of Quest Diagnostics worth $2.52M as of Q4 2017.
- Cornerstone Capital Management Holdings bought 1,889 Quest Diagnostics shares in Q4 2017, an estimated $179K.
- Quest Diagnostics made up 0.02% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #691 holding.
- Cornerstone Capital Management Holdings first reported a position in Quest Diagnostics in Q2 2013 and has held it in 19 quarters since.
- Cornerstone Capital Management Holdings's Quest Diagnostics position peaked at $9.22M in Q2 2015.
- 631 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2017.
Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.